Bartlett JG - Search Results

1

Factors associated with accelerated atherosclerosis in HIV-1-infected persons treated with protease inhibitors.

Lai S, Lai H, Celentano DD, Vlahov D, Ren S, Margolick J, Lima JA, Bartlett JG. Lai S, et al. Among authors: bartlett jg. AIDS Patient Care STDS. 2003 May;17(5):211-9. doi: 10.1089/108729103321655863. AIDS Patient Care STDS. 2003. PMID: 12816615

2

Human immunodeficiency virus 1 infection, cocaine, and coronary calcification.

Lai S, Lima JA, Lai H, Vlahov D, Celentano D, Tong W, Bartlett JG, Margolick J, Fishman EK. Lai S, et al. Among authors: bartlett jg. Arch Intern Med. 2005 Mar 28;165(6):690-5. doi: 10.1001/archinte.165.6.690. Arch Intern Med. 2005. PMID: 15795348

3

Prognostic indicators for AIDS and infectious disease death in HIV-infected injection drug users: plasma viral load and CD4+ cell count.

Vlahov D, Graham N, Hoover D, Flynn C, Bartlett JG, Margolick JB, Lyles CM, Nelson KE, Smith D, Holmberg S, Farzadegan H. Vlahov D, et al. Among authors: bartlett jg. JAMA. 1998 Jan 7;279(1):35-40. doi: 10.1001/jama.279.1.35. JAMA. 1998. PMID: 9424041

4

Heat-denatured human immunodeficiency virus type 1 protein 24 antigen: prognostic value in adults with early-stage disease.

Sterling TR, Hoover DR, Astemborski J, Vlahov D, Bartlett JG, Schupbach J. Sterling TR, et al. Among authors: bartlett jg. J Infect Dis. 2002 Oct 15;186(8):1181-5. doi: 10.1086/343807. Epub 2002 Sep 30. J Infect Dis. 2002. PMID: 12355373 Free article.

5

Provisional guidance on the use of hepatitis C virus protease inhibitors for treatment of hepatitis C in HIV-infected persons.

Thomas DL, Bartlett JG, Peters MG, Sherman KE, Sulkowski MS, Pham PA. Thomas DL, et al. Among authors: bartlett jg. Clin Infect Dis. 2012 Apr;54(7):979-83. doi: 10.1093/cid/cir882. Epub 2012 Feb 4. Clin Infect Dis. 2012. PMID: 22173234 Free PMC article.

6

Racial heterogeneity of HIV antigenemia in people with HIV infection.

Chaisson RE, Fuchs E, Stanton DL, Quinn TC, Hendricksen C, Bartlett JG, Farzadegan H. Chaisson RE, et al. Among authors: bartlett jg. AIDS. 1991 Feb;5(2):177-80. doi: 10.1097/00002030-199102000-00007. AIDS. 1991. PMID: 1903261

7

Costs of HIV medical care in the era of highly active antiretroviral therapy.

Gebo KA, Chaisson RE, Folkemer JG, Bartlett JG, Moore RD. Gebo KA, et al. Among authors: bartlett jg. AIDS. 1999 May 28;13(8):963-9. doi: 10.1097/00002030-199905280-00013. AIDS. 1999. PMID: 10371178

8

Association between use of HMG CoA reductase inhibitors and mortality in HIV-infected patients.

Moore RD, Bartlett JG, Gallant JE. Moore RD, et al. Among authors: bartlett jg. PLoS One. 2011;6(7):e21843. doi: 10.1371/journal.pone.0021843. Epub 2011 Jul 12. PLoS One. 2011. PMID: 21765919 Free PMC article.

9

Improvement in the health of HIV-infected persons in care: reducing disparities.

Moore RD, Keruly JC, Bartlett JG. Moore RD, et al. Among authors: bartlett jg. Clin Infect Dis. 2012 Nov;55(9):1242-51. doi: 10.1093/cid/cis654. Epub 2012 Sep 26. Clin Infect Dis. 2012. PMID: 23019271 Free PMC article.

10

Clostridium difficile in a HIV-infected cohort: incidence, risk factors, and clinical outcomes.

Haines CF, Moore RD, Bartlett JG, Sears CL, Cosgrove SE, Carroll K, Gebo KA. Haines CF, et al. Among authors: bartlett jg. AIDS. 2013 Nov 13;27(17):2799-807. doi: 10.1097/01.aids.0000432450.37863.e9. AIDS. 2013. PMID: 23842125 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

451 results

Search Page

Filters